Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2025-12-29 @ 6:14 PM
Study NCT ID:
NCT03463057
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-09-19
First Post:
2018-02-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Feasibility and Clinical Efficacy of Atezolizumab Consolidation Treatment in High Risk (IPI > 2) DLBCL
Sponsor:
Stichting Hemato-Oncologie voor Volwassenen Nederland
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-30
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-02-23
First Submit QC Date:
None
Study First Post Date:
2018-03-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-17
Last Update Post Date:
2024-09-19
Last Update Post Date Type:
ACTUAL